Ultragenyx Pharma (RARE) PT Raised to $90 at Stifel
Get Alerts RARE Hot Sheet
Price: $15.30 +3.03%
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Join SI Premium – FREE
Stifel raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $90.00 (from $77.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Downgrades Baltic Classifieds Group PLC (BCG:LN) to Underperform
- Scout24 (G24:GR) (SCOTF) PT Lowered to EUR102.50 at Jefferies
- Hemnet Group AB (HEM:SS) PT Lowered to SEK175 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share